Free Trial

Amneal Pharmaceuticals (AMRX) SEC Filings & 10K Form

Amneal Pharmaceuticals logo
$8.47 -0.53 (-5.89%)
(As of 11/15/2024 ET)

Recent Amneal Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/15/2024
12:49 PM
Amneal Pharmaceuticals (Subject)
Daly Jason B. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
5:08 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
5:51 PM
Amneal Pharmaceuticals (Subject)
Patel Chirag K. (Filed by)
Form SC 13D/A
10/30/2024
10:04 AM
Amneal Pharmaceuticals (Subject)
UBS Group AG (Filed by)
Form SCHEDULE 13G
10/01/2024
6:10 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
2:12 PM
Amneal Pharmaceuticals (Subject)
Shah Nikita (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
10:04 AM
Amneal Pharmaceuticals (Subject)
Shah Nikita (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
3:27 PM
Amneal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
5:14 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
2:13 PM
Amneal Pharmaceuticals (Subject)
Autor Deborah M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2024
3:38 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:39 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:40 PM
Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:41 PM
Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:42 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:43 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:44 PM
Amneal Pharmaceuticals (Issuer)
MEISTER PAUL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:45 PM
Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:45 PM
Alva Emily Peterson (Reporting)
Amneal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
3:46 PM
Amneal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
3:18 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
4:19 PM
Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:23 PM
Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:28 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:31 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:34 PM
Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:35 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:38 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:14 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
5:03 AM
Amneal Pharmaceuticals (Subject)
Fosun International Ltd (Filed by)
Form SC 13G/A
03/22/2024
7:01 AM
Amneal Pharmaceuticals (Filer)
Form DEF 14A
03/22/2024
7:01 AM
Amneal Pharmaceuticals (Filer)
Form DEFA14A
03/14/2024
4:04 PM
Amneal Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2024
4:39 PM
Amneal Pharmaceuticals (Issuer)
Patel Chirag K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:40 PM
Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:54 PM
Amneal Pharmaceuticals (Issuer)
Daly Jason B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:40 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
5:13 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
6:03 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
3:09 PM
Amneal Pharmaceuticals (Subject)
Mahesh Akram (Filed by)
Form SC 13G
01/03/2024
3:30 PM
Amneal Pharmaceuticals (Subject)
Patel Gautam (Filed by)
Form SC 13D/A
Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover
12/26/2023
6:06 PM
Amneal Pharmaceuticals (Filer)
Form CERT
12/26/2023
3:10 PM
Amneal Pharmaceuticals (Filer)
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
12/12/2023
5:04 AM
Amneal Pharmaceuticals (Subject)
Fosun International Ltd (Filed by)
Form SC 13G/A
11/20/2023
5:07 AM
Amneal Pharmaceuticals (Filer)
Form 15-12G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AMRX) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners